HCW Biologics is trading at $3.51 (9.6%) up today, extending a strong multi-day move that began late last week following a $1.6 million private placement.
- The stock continues to see significant investor enthusiasm, building on sharp gains recorded on July 30 and July 31.
- The recent capital injection has served as a primary catalyst for the current upward momentum in the pre-market session.